EAM Investors, LLC - GALECTIN THERAPEUTICS INC ownership

GALECTIN THERAPEUTICS INC's ticker is GALT and the CUSIP is 363225202. A total of 27 filers reported holding GALECTIN THERAPEUTICS INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
EAM Investors, LLC ownership history of GALECTIN THERAPEUTICS INC
ValueSharesWeighting
Q2 2018$1,389,000
-8.2%
218,429
-31.6%
0.22%
-13.1%
Q1 2018$1,513,000
-39.0%
319,187
+97.1%
0.25%
-43.6%
Q1 2014$2,479,000
+62.7%
161,935
+5.9%
0.45%
+47.0%
Q3 2013$1,524,000152,8540.30%
Other shareholders
GALECTIN THERAPEUTICS INC shareholders Q3 2013
NameSharesValueWeighting ↓
Cutter & CO Brokerage, Inc. 184,742$565,0000.18%
D.A. DAVIDSON & CO. 851,101$2,604,0000.05%
Iron Gate Global Advisors LLC 17,090$52,0000.02%
SHEPHERD KAPLAN KROCHUK, LLC 12,000$37,0000.02%
IHT Wealth Management, LLC 28,155$86,0000.01%
OSAIC HOLDINGS, INC. 1,012,430$3,098,0000.01%
Ameritas Investment Company, LLC 10,782$33,0000.01%
Vivaldi Capital Management LP 15,439$40,0000.01%
CENTAURUS FINANCIAL, INC. 15,614$48,0000.01%
Geneos Wealth Management Inc. 37,017$108,0000.01%
View complete list of GALECTIN THERAPEUTICS INC shareholders